-
公开(公告)号:EP4371569A1
公开(公告)日:2024-05-22
申请号:EP22383104.1
申请日:2022-11-16
IPC分类号: A61K39/00 , A61K39/385 , C07K14/005 , C07K14/47 , C07K14/82 , C12N7/04 , C12N15/866
CPC分类号: A61K39/0011 , A61K2039/80420180801 , A61K39/385 , A61K2039/607520130101 , A61K2039/58520130101 , C07K14/47 , C07K2319/73520130101 , C07K14/82 , C12N2770/2205220130101 , C12N2770/2202220130101 , C12N2770/2202320130101 , C12N2770/2204220130101 , C12N2710/1414320130101 , C12N2710/1414420130101 , C12N15/866 , C12N2800/4020130101 , C07K14/005 , C12N7/045
摘要: The present invention belongs to the field of human therapies as it proposes the use of a viral capsid as antigen carrier for making vaccines. The invention involves the design of virus-like particles (VLPs) comprising an acute myeloid leukaemia (AML)-specific antigen and the process for their production.
-
公开(公告)号:EP4401767A1
公开(公告)日:2024-07-24
申请号:EP22785904.8
申请日:2022-09-15
-
公开(公告)号:EP4416189A1
公开(公告)日:2024-08-21
申请号:EP22879729.6
申请日:2022-10-14
IPC分类号: C07K19/00 , A61K39/42 , A61K39/44 , A61K47/64 , A61K47/69 , A61P31/14 , C07K16/00 , C07K16/10
CPC分类号: A61P31/14 , C07K2317/56920130101 , C07K2319/73520130101 , C07K2317/9420130101 , C07K2317/7620130101 , C07K2319/0020130101 , C07K2317/6420130101 , C07K2317/5520130101 , C07K2317/5220130101 , C07K2317/9220130101 , C07K2317/3420130101 , C07K2317/3120130101 , A61K2039/50520130101 , A61K2039/50720130101 , A61K47/68 , A61K47/6811 , C07K16/1003
-
公开(公告)号:EP2970398B1
公开(公告)日:2024-05-08
申请号:EP14775224.0
申请日:2014-03-13
IPC分类号: C07K14/135 , A61K39/00 , A61K39/155 , A61K38/10 , A61P43/00 , C12N15/45 , C12N15/62
CPC分类号: A61K39/155 , A61K2039/5320130101 , A61K2039/5556120130101 , A61K2039/5556620130101 , C12N2760/1853420130101 , A61K2039/525220130101 , A61K2039/525420130101 , A61K2039/54320130101 , A61K2039/5550520130101 , C12N2710/1034320130101 , A61K39/12 , C07K2319/2120130101 , C07K2319/2220130101 , C07K2319/5020130101 , C07K2319/7020130101 , C07K2319/73520130101 , C12N2760/1852220130101 , C07K14/005 , A61P31/14 , A61P43/00
-
公开(公告)号:EP4351534A1
公开(公告)日:2024-04-17
申请号:EP22820975.5
申请日:2022-06-08
IPC分类号: A61K9/51 , A61K9/127 , A61K39/12 , A61K39/215 , A61P31/14 , C07K14/005 , C12N15/85 , A61K39/00
-
公开(公告)号:EP4436598A2
公开(公告)日:2024-10-02
申请号:EP22840429.9
申请日:2022-11-23
IPC分类号: A61K39/145 , C07K14/01 , C07K14/11 , C07K14/165 , C07K14/47 , C12N15/62
CPC分类号: A61P31/16 , A61K2039/5320130101 , A61K39/215 , A61P31/14 , A61K2039/5420130101 , A61K2039/54520130101 , A61K2039/57520130101 , A61K2039/57220130101 , A61K2039/5555520130101 , A61K2039/5556120130101 , A61K2039/5550520130101 , A61K39/145 , A61K2039/5556620130101 , C07K14/165 , C07K14/11 , C07K14/01 , C07K2319/73520130101 , C07K2319/7020130101 , C12N15/62 , C07K2319/0020130101 , C07K2319/4020130101
-
公开(公告)号:EP4421177A2
公开(公告)日:2024-08-28
申请号:EP24174501.7
申请日:2014-03-13
发明人: BOYINGTON, Jeffrey , GEORGIEV, Ivelin, Stefanov , PANCERA, Marie , SOTO, Cinque , SRIVATSAN, Sanjay , STEWART-JONES, Guillaume , KWONG, Peter, D. , GRAHAM, Barney, S. , MCLELLAN, Jason, S. , JOYCE, Michael, Gordon , KANEKIYO, Masaru , ZHANG, Baoshan , CHEN, Lei , CHEN, Man , CHUANG, Gwo-Yu , GORMAN, Jason , YANG, Yongping , ZHOU, Tongqing , SASTRY, Mallika , OFEK, Gilad
IPC分类号: C12N15/62
CPC分类号: A61K39/155 , A61K2039/5320130101 , A61K2039/5556120130101 , A61K2039/5556620130101 , C12N2760/1853420130101 , A61K2039/525220130101 , A61K2039/525420130101 , A61K2039/54320130101 , A61K2039/5550520130101 , C12N2710/1034320130101 , A61K39/12 , C07K2319/2120130101 , C07K2319/2220130101 , C07K2319/5020130101 , C07K2319/7020130101 , C07K2319/73520130101 , C12N2760/1852220130101 , C07K14/005 , A61P31/14 , A61P43/00
摘要: Disclosed are Respiratory Syncytial Virus (RSV) antigens including a recombinant RSV F protein stabilized in a prefusion conformation. Also disclosed are nucleic acids encoding the antigens and methods of producing the antigens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the antigen to the subject.
-
公开(公告)号:EP4413140A1
公开(公告)日:2024-08-14
申请号:EP22793205.0
申请日:2022-10-07
CPC分类号: C07K2319/8020130101 , C07K2319/8520130101 , C07K2319/73520130101 , C12N9/22 , C12N15/62 , C12N15/102 , C12N2310/2020170501
-
公开(公告)号:EP4392066A1
公开(公告)日:2024-07-03
申请号:EP22768820.7
申请日:2022-08-24
申请人: Osivax , OSIVAX Belgique
发明人: LE VERT, Alexandre , BOULEY, Julien , NICOLAS, Florence , WILLEMS, Paul , GUYON-GELLIN, Delphine
IPC分类号: A61K39/145 , A61P31/16 , A61P37/04 , C07K14/11
-
公开(公告)号:EP4441074A2
公开(公告)日:2024-10-09
申请号:EP22854318.7
申请日:2022-12-02
发明人: LIU, David R. , CAHILL, Thomas J. III , DESOUZA, Philip , RAGURAM, Aditya , BANSKOTA, Samagya , AN, Meirui
IPC分类号: C07K14/005 , C12N7/00 , C07K14/47 , C12N9/22 , C12N15/10 , C12N15/113 , C12N15/62 , C12N15/86
CPC分类号: C07K14/005 , C12N15/86 , C12N2740/1304520130101 , C12N2740/1302220130101 , C12N2740/1302320130101 , C12N9/22 , C12N15/102 , C12N15/1137 , C07K2319/09520130101 , C07K2319/03320130101 , C07K2319/5020130101 , C07K2319/73520130101 , C07K2319/0920130101 , C07K14/4713 , C12Y201/01037 , C12N2310/2020170501 , C12N15/113 , C12N15/1138
-
-
-
-
-
-
-
-
-